QTRX
Quanterix Corp
Company overview
- Market capitalization
- $166.47M
- Employees
- 450
- Latest publication
- 2026-09-29
About Quanterix Corp
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, the company offers contract research and clinical laboratory testing services, including research and clinical trial testing, and lucent diagnostic services. The company primarily operates in the areas of neurology, oncology and immunology, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and sales force and distributors. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q3 20202020-09-30 · USD | Q4 20152015-12-31 · USD |
|---|---|---|
| Total Revenue | 29,460,000USD | 12,180,000USD |
| Cost Of Revenue | 10,283,000USD | 6,040,000USD |
| Gross Profit | 19,177,000USD | -4,368,000USD |
| Research Development | 5,377,000USD | 10,083,000USD |
| Selling General Administrative | 13,451,000USD | 20,238,000USD |
| Unclassified Operating Expenses | -1,929,000USD | -3,618,000USD |
| Total Operating Expenses | 16,899,000USD | 26,703,000USD |
| Operating Income | 2,278,000USD | -14,523,000USD |
| Interest Expense | 160,000USD | 1,040,000USD |
| Net Interest Income | -160,000USD | — |
| Income Before Tax | 2,092,000USD | -15,943,000USD |
| Income Tax Expense | -111,000USD | 0USD |
| Tax Provision | -111,000USD | — |
| Net Income | 2,203,000USD | -15,943,000USD |
| Net Income From Continuing Ops | 2,203,000USD | -15,943,000USD |
| Ebit | 2,252,000USD | -14,523,000USD |
| Ebitda | 3,360,000USD | — |
| Depreciation And Amortization | 1,108,000USD | — |
| Reconciled Depreciation | 1,108,000USD | — |
| Total Other Income Expense Net | -186,000USD | -1,420,000USD |
| Non Operating Income Net Other | -26,000USD | — |
| Net Income Applicable To Common Shares | 2,203,000USD | -20,298,000USD |
| Minority Interest | — | 0USD |
| Discontinued Operations | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 366,672,000USD | 418,766,000USD | 444,140,000USD | 375,609,000USD | 396,512,000USD | 406,533,000USD | 411,026,000USD | 411,288,000USD |
| Intangible Assets | 109,161,000USD | 131,787,000USD | 135,148,000USD | 16,332,000USD | 16,520,000USD | 4,031,000USD | 4,782,000USD | 4,981,000USD |
| Other Current Assets | 8,725,000USD | 9,290,000USD | 10,483,000USD | 7,254,000USD | 8,839,000USD | 9,556,000USD | 9,379,000USD | 8,724,000USD |
| Total Liab | 84,533,000USD | 123,036,000USD | 129,606,000USD | 83,151,000USD | 80,119,000USD | 76,495,000USD | 72,144,000USD | 74,536,000USD |
| Total Stockholder Equity | 282,139,000USD | 295,730,000USD | 314,534,000USD | 292,458,000USD | 316,393,000USD | 330,038,000USD | 338,882,000USD | 336,752,000USD |
| Other Current Liab | 18,125,000USD | 32,550,000USD | 35,925,000USD | 24,498,000USD | 18,540,000USD | 20,453,000USD | 15,428,000USD | 14,853,000USD |
| Common Stock | 47,000USD | 47,000USD | 47,000USD | 39,000USD | 39,000USD | 39,000USD | 39,000USD | 38,000USD |
| Capital Stock | 47,000USD | 47,000USD | 47,000USD | 39,000USD | 39,000USD | 39,000USD | 39,000USD | 38,000USD |
| Retained Earnings | -594,772,000USD | -577,231,000USD | -554,115,000USD | -520,598,000USD | -490,585,000USD | -470,081,000USD | -458,453,000USD | -454,041,000USD |
| Good Will | 26,710,000USD | 26,376,000USD | 23,460,000USD | — | 6,574,000USD | 0USD | — | — |
| Cash | 36,182,000USD | 29,839,000USD | 38,298,000USD | 132,896,000USD | 76,508,000USD | 56,709,000USD | 29,339,000USD | 47,002,000USD |
| Cash And Short Term Investments | 99,265,000USD | 118,232,000USD | 134,809,000USD | 261,172,000USD | 266,877,000USD | 289,122,000USD | 293,523,000USD | 296,855,000USD |
| Total Current Assets | 185,725,000USD | 212,257,000USD | 233,278,000USD | 322,117,000USD | 335,002,000USD | 363,594,000USD | 366,960,000USD | 365,726,000USD |
| Total Current Liabilities | 49,905,000USD | 74,762,000USD | 77,352,000USD | 48,202,000USD | 40,395,000USD | 42,007,000USD | 36,454,000USD | 37,539,000USD |
| Current Deferred Revenue | 15,190,000USD | 20,728,000USD | 20,913,000USD | 9,427,000USD | 9,102,000USD | 8,827,000USD | 8,984,000USD | 10,121,000USD |
| Net Debt | -846,000USD | 7,400,000USD | 1,822,000USD | -97,362,000USD | -40,101,000USD | -19,338,000USD | 9,152,000USD | -7,426,000USD |
| Short Term Debt | 7,933,000USD | 7,916,000USD | 8,412,000USD | 5,153,000USD | 4,940,000USD | 4,756,000USD | 4,641,000USD | 4,524,000USD |
| Short Long Term Debt Total | 35,336,000USD | 37,239,000USD | 40,120,000USD | 35,534,000USD | 36,407,000USD | 37,371,000USD | 38,491,000USD | 39,576,000USD |
| Short Term Investments | 63,083,000USD | 88,393,000USD | 96,511,000USD | 128,276,000USD | 190,369,000USD | 232,413,000USD | 264,184,000USD | 249,853,000USD |
| Net Receivables | 26,776,000USD | 29,972,000USD | 33,029,000USD | 23,549,000USD | 28,258,000USD | 32,141,000USD | 31,089,000USD | 31,784,000USD |
| Inventory | 50,959,000USD | 54,763,000USD | 54,957,000USD | 30,142,000USD | 31,028,000USD | 32,775,000USD | 32,969,000USD | 28,363,000USD |
| Accounts Payable | 8,657,000USD | 13,568,000USD | 10,633,000USD | 9,124,000USD | 6,731,000USD | 6,953,000USD | 6,378,000USD | 7,273,000USD |
| Property Plant Equipment Net | 37,230,000USD | 40,336,000USD | 44,866,000USD | 31,458,000USD | 32,428,000USD | 33,489,000USD | 34,538,000USD | 35,604,000USD |
| Property Plant Equipment Gross | 37,230,000USD | 66,163,000USD | 44,866,000USD | 31,458,000USD | 32,428,000USD | 52,313,000USD | 34,538,000USD | 35,604,000USD |
| Accumulated Other Comprehensive Income | -1,013,000USD | -723,000USD | -818,000USD | -928,000USD | -1,821,000USD | -3,080,000USD | -1,411,000USD | -3,151,000USD |
| Common Stock Shares Outstanding | 46,979,000shares | 46,780,000shares | 46,060,000shares | 38,893,000shares | 38,718,000shares | 38,551,000shares | 38,449,000shares | 38,338,000shares |
| Non Current Assets Total | 180,947,000USD | 206,509,000USD | 210,862,000USD | 53,492,000USD | 61,510,000USD | 42,939,000USD | 44,066,000USD | 45,562,000USD |
| Non Current Liabilities Total | 34,628,000USD | 48,274,000USD | 52,254,000USD | 34,949,000USD | 39,724,000USD | 34,488,000USD | 35,690,000USD | 36,997,000USD |
| Non Current Liabilities Other | 3,547,000USD | 5,024,000USD | 13,205,000USD | 3,512,000USD | 7,159,000USD | — | 956,000USD | 1,017,000USD |
| Non Currrent Assets Other | 7,846,000USD | 8,010,000USD | 7,388,000USD | 2,261,000USD | 5,988,000USD | 5,419,000USD | 4,746,000USD | 4,977,000USD |
| Net Working Capital | 135,820,000USD | 137,495,000USD | 155,926,000USD | 273,915,000USD | 294,607,000USD | 321,587,000USD | 330,506,000USD | 328,187,000USD |
| Unclassified Non Current Liabilities | 31,081,000USD | 43,250,000USD | 39,049,000USD | 31,437,000USD | 32,565,000USD | 34,488,000USD | 34,734,000USD | 35,980,000USD |
| Unclassified Equity | 877,830,000USD | 873,590,000USD | 869,373,000USD | 813,906,000USD | 808,721,000USD | 803,121,000USD | 798,668,000USD | 793,868,000USD |
| Unclassified Current Liabilities | — | — | 1,469,000USD | — | 1,082,000USD | 1,018,000USD | 1,023,000USD | — |
| Unclassified Non Current Assets | — | — | — | 3,441,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 418,766,000USD | 406,533,000USD | 428,567,000USD | 433,582,000USD | 506,514,000USD | 271,045,000USD | 169,951,000USD | 67,628,000USD |
| Intangible Assets | 131,787,000USD | 4,031,000USD | 6,034,000USD | 7,516,000USD | 10,534,000USD | 13,716,000USD | 14,307,000USD | 2,349,000USD |
| Other Current Assets | 9,290,000USD | 9,556,000USD | 9,234,000USD | 6,803,000USD | 6,514,000USD | 5,981,000USD | 2,137,000USD | 2,330,000USD |
| Total Liab | 123,036,000USD | 76,495,000USD | 78,609,000USD | 75,650,000USD | 65,562,000USD | 64,920,000USD | 41,293,000USD | 26,072,000USD |
| Total Stockholder Equity | 295,730,000USD | 330,038,000USD | 349,958,000USD | 357,932,000USD | 440,952,000USD | 206,125,000USD | 128,658,000USD | 41,556,000USD |
| Other Current Liab | 32,550,000USD | 20,453,000USD | 19,403,000USD | 16,182,000USD | 19,979,000USD | 18,520,000USD | 9,284,000USD | 7,578,000USD |
| Common Stock | 47,000USD | 39,000USD | 38,000USD | 37,000USD | 37,000USD | 32,000USD | 28,000USD | 22,000USD |
| Capital Stock | 47,000USD | 39,000USD | 38,000USD | 37,000USD | 37,000USD | 32,000USD | 28,000USD | 22,000USD |
| Retained Earnings | -577,231,000USD | -470,081,000USD | -431,550,000USD | -403,196,000USD | -305,462,000USD | -247,774,000USD | -216,244,000USD | -175,888,000USD |
| Good Will | 26,376,000USD | 0USD | — | 0USD | 9,632,000USD | 10,460,000USD | 9,353,000USD | 1,308,000USD |
| Cash | 29,839,000USD | 56,709,000USD | 174,422,000USD | 338,740,000USD | 396,465,000USD | 181,584,000USD | 109,155,000USD | 45,429,000USD |
| Cash And Short Term Investments | 118,232,000USD | 289,122,000USD | 321,324,000USD | 338,740,000USD | 396,465,000USD | 181,584,000USD | 109,155,000USD | 45,429,000USD |
| Total Current Assets | 212,257,000USD | 363,594,000USD | 382,095,000USD | 381,524,000USD | 448,955,000USD | 219,605,000USD | 132,661,000USD | 60,513,000USD |
| Total Current Liabilities | 74,762,000USD | 42,007,000USD | 38,982,000USD | 31,349,000USD | 36,977,000USD | 39,803,000USD | 19,833,000USD | 17,657,000USD |
| Current Deferred Revenue | 20,728,000USD | 8,827,000USD | 9,468,000USD | 8,644,000USD | 6,361,000USD | 5,421,000USD | 4,697,000USD | 5,437,000USD |
| Net Debt | 7,400,000USD | -19,338,000USD | -132,958,000USD | -294,636,000USD | -374,573,000USD | -150,786,000USD | -101,493,000USD | -37,806,000USD |
| Short Term Debt | 7,916,000USD | 4,756,000USD | 4,241,000USD | 2,687,000USD | 1,428,000USD | 8,907,000USD | 75,000USD | 468,000USD |
| Short Long Term Debt Total | 37,239,000USD | 37,371,000USD | 41,464,000USD | 44,104,000USD | 21,892,000USD | 30,798,000USD | 7,662,000USD | 8,091,000USD |
| Short Term Investments | 88,393,000USD | 232,413,000USD | 146,902,000USD | 0USD | — | — | — | — |
| Net Receivables | 29,972,000USD | 32,141,000USD | 25,414,000USD | 19,017,000USD | 23,786,000USD | 17,184,000USD | 10,906,000USD | 6,792,000USD |
| Inventory | 54,763,000USD | 32,775,000USD | 26,123,000USD | 16,964,000USD | 22,190,000USD | 14,856,000USD | 10,463,000USD | 5,962,000USD |
| Accounts Payable | 13,568,000USD | 6,953,000USD | 5,048,000USD | 3,836,000USD | 9,209,000USD | 6,799,000USD | 5,777,000USD | 5,110,000USD |
| Property Plant Equipment Net | 40,336,000USD | 33,489,000USD | 36,177,000USD | 41,034,000USD | 29,451,000USD | 25,907,000USD | 12,047,000USD | 2,923,000USD |
| Property Plant Equipment Gross | 66,163,000USD | 52,313,000USD | 50,298,000USD | 20,162,000USD | 17,960,000USD | 25,907,000USD | 12,047,000USD | 2,923,000USD |
| Accumulated Other Comprehensive Income | -723,000USD | -3,080,000USD | -1,672,000USD | -2,538,000USD | 441,000USD | 2,434,000USD | -153,000USD | -3,023,000USD |
| Common Stock Shares Outstanding | 42,639,000shares | 38,367,000shares | 37,594,000shares | 36,990,965shares | 35,997,473shares | 29,589,132shares | 25,090,708shares | 22,369,036shares |
| Non Current Assets Total | 206,509,000USD | 42,939,000USD | 46,472,000USD | 52,057,999USD | 57,559,000USD | 51,440,000USD | 37,290,000USD | 7,115,000USD |
| Non Current Liabilities Total | 48,274,000USD | 34,488,000USD | 39,627,000USD | 44,301,000USD | 28,585,000USD | 25,117,000USD | 21,460,000USD | 8,415,000USD |
| Non Current Liabilities Other | 5,024,000USD | — | — | 1,469,000USD | 2,035,000USD | 2,649,000USD | 7,573,000USD | 278,000USD |
| Non Currrent Assets Other | 8,010,000USD | 5,419,000USD | 4,261,000USD | -6,862,000USD | 378,000USD | 1,357,000USD | -1,666,000USD | 536,000USD |
| Net Working Capital | 137,495,000USD | 321,587,000USD | 339,937,000USD | 350,445,000USD | 411,978,000USD | 179,802,000USD | 112,828,000USD | 41,371,000USD |
| Unclassified Non Current Liabilities | 43,250,000USD | 34,488,000USD | 39,627,000USD | 39,948,000USD | 23,416,000USD | 19,242,000USD | -7,573,000USD | — |
| Unclassified Equity | 873,590,000USD | 803,121,000USD | 783,104,000USD | 763,592,000USD | 745,899,000USD | 451,401,000USD | 344,999,000USD | 220,423,000USD |
| Unclassified Current Liabilities | — | 1,018,000USD | — | — | — | -7,517,000USD | — | — |
| Other Liab | — | — | — | 2,884,000USD | 3,134,000USD | 3,226,000USD | 13,873,000USD | 798,000USD |
| Other Assets | — | — | — | 3,895,000USD | 2,955,000USD | 13,352,000USD | 1,583,000USD | 1,036,000USD |
| Net Tangible Assets | — | — | — | 358,940,000USD | 420,786,000USD | 206,125,000USD | 104,998,000USD | 37,409,000USD |
| Unclassified Non Current Assets | — | — | — | — | 4,609,000USD | -13,352,000USD | — | -1,537,000USD |
| Short Long Term Debt | — | — | — | — | — | 7,673,000USD | 75,000USD | — |
| Long Term Debt | — | — | — | — | — | — | 7,587,000USD | 7,623,000USD |
| Long Term Investments | — | — | — | — | — | — | 500,000USD | 500,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -17,541,000USD | -23,117,000USD | -33,517,000USD | -30,013,000USD | -20,504,000USD | -11,628,000USD | -8,353,000USD | -7,387,000USD |
| Depreciation | 6,400,000USD | 7,249,000USD | 6,639,000USD | 2,288,000USD | 2,749,000USD | 2,245,000USD | 2,147,000USD | 1,963,000USD |
| Stock Based Compensation | 4,528,000USD | 4,415,000USD | 5,469,000USD | 5,372,000USD | 5,462,000USD | 4,837,000USD | 4,657,000USD | 5,228,000USD |
| Other Non Cash Items | 23,032,000USD | -3,185,000USD | 6,863,000USD | 1,240,000USD | -959,000USD | 3,609,000USD | 2,651,000USD | 3,698,000USD |
| Change To Account Receivables | 2,717,000USD | 2,708,000USD | -1,575,000USD | 5,147,000USD | 4,329,000USD | -1,302,000USD | 840,000USD | -3,009,000USD |
| Change To Inventory | 3,221,000USD | -171,000USD | 1,211,000USD | 908,000USD | 2,085,000USD | 166,000USD | 238,000USD | -4,552,000USD |
| Change In Working Capital | -16,023,000USD | -1,617,000USD | -15,556,000USD | 15,458,000USD | -636,000USD | 1,472,000USD | -2,192,000USD | -3,225,000USD |
| Total Cash From Operating Activities | -18,107,000USD | -16,444,000USD | -41,249,000USD | -5,655,000USD | -13,888,000USD | -4,302,000USD | -5,747,000USD | -4,951,000USD |
| Capital Expenditures | -87,000USD | -98,000USD | -677,000USD | -777,000USD | -1,256,000USD | -412,000USD | -851,000USD | -1,599,000USD |
| Free Cash Flow | -18,194,000USD | -16,346,000USD | -41,926,000USD | -6,432,000USD | -15,144,000USD | -4,714,000USD | -6,598,000USD | -6,550,000USD |
| Investments | 25,350,000USD | 8,341,000USD | -52,850,000USD | 61,880,000USD | 32,762,000USD | 32,384,000USD | -12,429,000USD | 6,975,000USD |
| Total Cashflows From Investing Activities | 25,263,000USD | 8,439,000USD | -52,850,000USD | 61,880,000USD | 32,762,000USD | 32,384,000USD | -12,429,000USD | 6,975,000USD |
| Net Borrowings | -83,000USD | — | — | — | 0USD | — | — | — |
| Total Cash From Financing Activities | -770,000USD | -522,000USD | 150,000USD | -429,000USD | 93,000USD | 41,000USD | 144,000USD | -328,000USD |
| Change In Cash | 6,343,000USD | -8,454,000USD | -94,597,999USD | 56,390,000USD | 19,828,000USD | 27,370,000USD | -17,663,000USD | 1,721,000USD |
| Begin Period Cash Flow | 29,839,000USD | 41,634,000USD | 132,895,999USD | 79,147,000USD | 59,319,000USD | 29,339,000USD | 47,002,000USD | 45,281,000USD |
| End Period Cash Flow | 36,182,000USD | 33,180,000USD | 38,298,000USD | 135,537,000USD | 79,147,000USD | 56,709,000USD | 29,339,000USD | 47,002,000USD |
| Other Cashflows From Financing Activities | -1,027,000USD | -436,000USD | -6,000USD | -429,000USD | -575,000USD | -26,000USD | -434,000USD | -712,000USD |
| Unclassified Operating Cash Flow | -18,503,000USD | — | -11,147,000USD | — | — | -4,837,000USD | -4,657,000USD | -5,228,000USD |
| Sale Purchase Of Stock | — | — | — | -429,000USD | — | — | -434,000USD | -712,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | 1,256,000USD | — | — | 1,599,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | 1,012,000USD | 1,096,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -107,150,000USD | -38,531,000USD | -32,334,000USD | -96,700,000USD | -57,688,000USD | -31,530,000USD | -40,796,000USD | -31,536,000USD |
| Depreciation | 18,925,000USD | 8,356,000USD | 8,379,000USD | 5,349,000USD | 4,851,000USD | 4,312,000USD | 3,009,000USD | 1,352,000USD |
| Stock Based Compensation | 20,718,000USD | 19,987,000USD | 16,764,000USD | 15,442,000USD | 15,975,000USD | 10,099,000USD | 6,388,000USD | 4,884,000USD |
| Other Non Cash Items | -1,511,000USD | -6,190,000USD | 92,000USD | 25,793,000USD | 340,000USD | 808,000USD | 700,000USD | 170,000USD |
| Change To Account Receivables | 10,609,000USD | -7,704,000USD | -6,695,000USD | 5,156,000USD | -6,853,000USD | -6,240,000USD | -3,365,000USD | -983,000USD |
| Change To Inventory | 4,033,000USD | -6,679,000USD | -5,364,000USD | 5,386,000USD | -8,090,000USD | -5,119,000USD | -3,447,000USD | -1,603,000USD |
| Change In Working Capital | -2,351,000USD | -18,786,000USD | -11,803,000USD | 2,070,000USD | -12,186,000USD | -7,470,000USD | 4,372,000USD | -3,577,000USD |
| Total Cash From Operating Activities | -77,236,000USD | -35,164,000USD | -18,902,000USD | -48,272,000USD | -47,907,000USD | -23,365,000USD | -26,187,000USD | -28,721,000USD |
| Capital Expenditures | -2,612,000USD | -3,368,000USD | -3,788,000USD | -11,726,000USD | -13,616,000USD | -3,930,000USD | -10,847,000USD | -1,518,000USD |
| Free Cash Flow | -79,848,000USD | -38,532,000USD | -22,690,000USD | -59,998,000USD | -61,523,000USD | -27,295,000USD | -37,034,000USD | -30,239,000USD |
| Investments | 146,072,000USD | -82,265,000USD | -128,367,000USD | -11,206,000USD | -6,338,000USD | -626,000USD | -25,376,000USD | -150,000USD |
| Total Cashflows From Investing Activities | 50,231,000USD | -82,265,000USD | -148,401,000USD | -11,206,000USD | -6,338,000USD | -626,000USD | -25,376,000USD | -5,454,000USD |
| Total Cash From Financing Activities | -708,000USD | 456,000USD | 2,691,000USD | 2,311,000USD | 270,795,000USD | 96,236,000USD | 116,197,000USD | -78,000USD |
| Change In Cash | -26,139,000USD | -117,707,000USD | -164,311,000USD | -57,705,000USD | 216,458,000USD | 72,403,000USD | 64,752,000USD | -34,253,000USD |
| Begin Period Cash Flow | 59,319,000USD | 177,026,000USD | 341,337,000USD | 399,042,000USD | 182,584,000USD | 110,181,000USD | 45,429,000USD | 79,682,000USD |
| End Period Cash Flow | 33,180,000USD | 59,319,000USD | 177,026,000USD | 341,337,000USD | 399,042,000USD | 182,584,000USD | 110,181,000USD | 45,429,000USD |
| Other Cashflows From Financing Activities | -1,446,000USD | -2,610,000USD | -198,000USD | 2,311,000USD | 8,815,000USD | 4,907,000USD | 3,699,000USD | 1,871,000USD |
| Unclassified Operating Cash Flow | -5,867,000USD | — | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | -93,229,000USD | 3,368,000USD | -16,246,000USD | 11,206,000USD | 6,338,000USD | — | 25,376,000USD | -3,801,000USD |
| Unclassified Financing Cash Flow | — | 3,066,000USD | 3,087,000USD | -2,311,000USD | -8,815,000USD | -4,907,000USD | -3,699,000USD | — |
| Net Borrowings | — | — | 0USD | 0USD | -7,738,000USD | -75,000USD | -50,000USD | -1,929,000USD |
| Sale Purchase Of Stock | — | — | -198,000USD | 2,311,000USD | 278,533,000USD | 96,311,000USD | 116,247,000USD | -20,000USD |
| Issuance Of Capital Stock | — | — | 0USD | 0USD | 269,718,000USD | 91,404,000USD | 112,548,000USD | 0USD |
| Change To Liabilities | — | — | — | -6,729,000USD | 4,574,000USD | 7,215,000USD | 10,580,000USD | 570,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -57,167,000USD | 216,550,000USD | 72,245,000USD | 64,634,000USD | -34,253,000USD |
| Other Cashflows From Investing Activities | — | — | — | 520,000USD | 7,278,000USD | 3,304,000USD | -14,529,000USD | 15,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q3 2025Quarterly · 2025-09-30 | Product | Consumable And Other Products | 18,954,000 | USD | 0001503274-25-000106 |
| Q3 2025Quarterly · 2025-09-30 | Product | Grant | 83,000 | USD | 0001503274-25-000106 |
| Q3 2025Quarterly · 2025-09-30 | Product | Instruments | 7,197,000 | USD | 0001503274-25-000106 |
| Q3 2025Quarterly · 2025-09-30 | Product | License And Service | 46,000 | USD | 0001503274-25-000106 |
| Q3 2025Quarterly · 2025-09-30 | Product | Other Services | 2,927,000 | USD | 0001503274-25-000106 |
| Q3 2025Quarterly · 2025-09-30 | Product | Service And Other Revenue — Research Services | 8,043,000 | USD | 0001503274-25-000106 |
| Q3 2025Quarterly · 2025-09-30 | Product | Service Type Warranties | 2,983,000 | USD | 0001503274-25-000106 |
| Q2 2025Quarterly · 2025-06-30 | Product | Consumable And Other Products | 14,872,000 | USD | 0001503274-25-000091 |
| Q2 2025Quarterly · 2025-06-30 | Product | Grant | 22,000 | USD | 0001503274-25-000091 |
| Q2 2025Quarterly · 2025-06-30 | Product | Instruments | 1,960,000 | USD | 0001503274-25-000091 |
| Q2 2025Quarterly · 2025-06-30 | Product | License And Service | 532,000 | USD | 0001503274-25-000091 |
| Q2 2025Quarterly · 2025-06-30 | Product | Other Services | 494,000 | USD | 0001503274-25-000091 |
| Q2 2025Quarterly · 2025-06-30 | Product | Service And Other Revenue — Research Services | 4,023,000 | USD | 0001503274-25-000091 |
| Q2 2025Quarterly · 2025-06-30 | Product | Service Type Warranties | 2,573,000 | USD | 0001503274-25-000091 |
| Q1 2025Quarterly · 2025-03-31 | Product | License And Service | 771,000 | USD | 0001503274-26-000021 |
| Q1 2025Quarterly · 2025-03-31 | Product | Other Services | 628,000 | USD | 0001503274-26-000021 |
| Q1 2025Quarterly · 2025-03-31 | Product | Service Type Warranties | 2,594,000 | USD | 0001503274-26-000021 |
| Q1 2025Quarterly · 2025-03-31 | Product | Simoa Product Revenue — Consumable And Other Products | 18,116,000 | USD | 0001503274-26-000021 |
| Q1 2025Quarterly · 2025-03-31 | Product | Simoa Product Revenue — Instruments | 2,623,000 | USD | 0001503274-26-000021 |
| Q1 2025Quarterly · 2025-03-31 | Product | Simoa Service And Other Revenue — Research Services | 5,601,000 | USD | 0001503274-26-000021 |
| Q1 2025Quarterly · 2025-03-31 | Product | Spatial Product Revenue | 0 | USD | 0001503274-26-000021 |
| Q1 2025Quarterly · 2025-03-31 | Product | Spatial Service And Other Revenue | 0 | USD | 0001503274-26-000021 |
| FY 2024Yearly · 2024-12-31 | Product | Grant | 1,985,000 | USD | 0001503274-26-000013 |
| FY 2024Yearly · 2024-12-31 | Product | License And Service | 4,452,000 | USD | 0001503274-26-000013 |
| FY 2024Yearly · 2024-12-31 | Product | Other Services | 2,639,000 | USD | 0001503274-26-000013 |
| FY 2024Yearly · 2024-12-31 | Product | Service Type Warranties | 10,607,000 | USD | 0001503274-26-000013 |
| FY 2024Yearly · 2024-12-31 | Product | Simoa Product Revenue — Consumable And Other Products | 69,260,000 | USD | 0001503274-26-000013 |
| FY 2024Yearly · 2024-12-31 | Product | Simoa Product Revenue — Instrument Products | 10,480,000 | USD | 0001503274-26-000013 |
| FY 2024Yearly · 2024-12-31 | Product | Simoa Service And Other Revenue — Research Services | 37,998,000 | USD | 0001503274-26-000013 |
| FY 2024Yearly · 2024-12-31 | Product | Spatial Product Revenue | 0 | USD | 0001503274-26-000013 |
| FY 2024Yearly · 2024-12-31 | Product | Spatial Service And Other Revenue | 0 | USD | 0001503274-26-000013 |
| Q3 2024Quarterly · 2024-09-30 | Product | Consumable And Other Products | 17,308,000 | USD | 0001503274-25-000106 |
| Q3 2024Quarterly · 2024-09-30 | Product | Grant | 402,000 | USD | 0001503274-25-000106 |
| Q3 2024Quarterly · 2024-09-30 | Product | Instruments | 2,386,000 | USD | 0001503274-25-000106 |
| Q3 2024Quarterly · 2024-09-30 | Product | License And Service | 1,872,000 | USD | 0001503274-25-000106 |
| Q3 2024Quarterly · 2024-09-30 | Product | Other Services | 707,000 | USD | 0001503274-25-000106 |
| Q3 2024Quarterly · 2024-09-30 | Product | Service And Other Revenue — Research Services | 10,543,000 | USD | 0001503274-25-000106 |
| Q3 2024Quarterly · 2024-09-30 | Product | Service Type Warranties | 2,595,000 | USD | 0001503274-25-000106 |
| Q2 2024Quarterly · 2024-06-30 | Product | Consumable And Other Products | 17,421,000 | USD | 0001503274-25-000091 |
| Q2 2024Quarterly · 2024-06-30 | Product | Grant | 254,000 | USD | 0001503274-25-000091 |
| Q2 2024Quarterly · 2024-06-30 | Product | Instruments | 2,466,000 | USD | 0001503274-25-000091 |
| Q2 2024Quarterly · 2024-06-30 | Product | License And Service | 729,000 | USD | 0001503274-25-000091 |
| Q2 2024Quarterly · 2024-06-30 | Product | Other Services | 670,000 | USD | 0001503274-25-000091 |
| Q2 2024Quarterly · 2024-06-30 | Product | Service And Other Revenue — Research Services | 10,128,000 | USD | 0001503274-25-000091 |
| Q2 2024Quarterly · 2024-06-30 | Product | Service Type Warranties | 2,713,000 | USD | 0001503274-25-000091 |
| Q1 2024Quarterly · 2024-03-31 | Product | Consumable And Other Products | 17,124,000 | USD | 0001503274-25-000054 |
| Q1 2024Quarterly · 2024-03-31 | Product | Grant | 274,000 | USD | 0001503274-25-000054 |
| Q1 2024Quarterly · 2024-03-31 | Product | Instruments | 2,546,000 | USD | 0001503274-25-000054 |
| Q1 2024Quarterly · 2024-03-31 | Product | License And Service | 155,000 | USD | 0001503274-25-000054 |
| Q1 2024Quarterly · 2024-03-31 | Product | Other Services | 593,000 | USD | 0001503274-25-000054 |
| Q1 2024Quarterly · 2024-03-31 | Product | Service And Other Revenue — Research Services | 8,691,000 | USD | 0001503274-25-000054 |
| Q1 2024Quarterly · 2024-03-31 | Product | Service Type Warranties | 2,683,000 | USD | 0001503274-25-000054 |
| Q4 2023Quarterly · 2023-12-31 | Product | Grant | 352,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | License And Service | 146,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | Other Services | 506,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | Service Type Warranties | 2,450,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | Simoa Product Revenue — Consumable And Other Products | 17,729,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | Simoa Product Revenue — Instrument Products | 3,302,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | Simoa Service And Other Revenue — Research Services | 7,064,000 | USD | Legacy provider |
| FY 2023Yearly · 2023-12-31 | Product | Grant | 1,229,000 | USD | 0001503274-26-000013 |
| FY 2023Yearly · 2023-12-31 | Product | License And Service | 1,380,000 | USD | 0001503274-26-000013 |
| FY 2023Yearly · 2023-12-31 | Product | Other Services | 2,382,000 | USD | 0001503274-26-000013 |
| FY 2023Yearly · 2023-12-31 | Product | Service Type Warranties | 9,879,000 | USD | 0001503274-26-000013 |
| FY 2023Yearly · 2023-12-31 | Product | Simoa Product Revenue — Consumable And Other Products | 63,965,000 | USD | 0001503274-26-000013 |
| FY 2023Yearly · 2023-12-31 | Product | Simoa Product Revenue — Instrument Products | 15,705,000 | USD | 0001503274-26-000013 |
| FY 2023Yearly · 2023-12-31 | Product | Simoa Service And Other Revenue — Research Services | 27,828,000 | USD | 0001503274-26-000013 |
| FY 2023Yearly · 2023-12-31 | Product | Spatial Product Revenue | 0 | USD | 0001503274-26-000013 |
| FY 2023Yearly · 2023-12-31 | Product | Spatial Service And Other Revenue | 0 | USD | 0001503274-26-000013 |
| Q3 2023Quarterly · 2023-09-30 | Product | Consumable And Other Products | 16,058,000 | USD | 0001503274-24-000031 |
| Q3 2023Quarterly · 2023-09-30 | Product | Grant | 499,000 | USD | 0001503274-24-000031 |
| Q3 2023Quarterly · 2023-09-30 | Product | Instruments | 3,882,000 | USD | 0001503274-24-000031 |
| Q3 2023Quarterly · 2023-09-30 | Product | License And Service | 237,000 | USD | 0001503274-24-000031 |
| Q3 2023Quarterly · 2023-09-30 | Product | Other Services | 632,000 | USD | 0001503274-24-000031 |
| Q3 2023Quarterly · 2023-09-30 | Product | Research Services | 7,740,000 | USD | 0001503274-24-000031 |
| Q3 2023Quarterly · 2023-09-30 | Product | Service Type Warranties | 2,511,000 | USD | 0001503274-24-000031 |
| Q3 2023Quarterly · 2023-09-30 | Geography | Asia Pacific | 3,940,000 | USD | 0001558370-23-018091 |
| Q3 2023Quarterly · 2023-09-30 | Geography | EMEA | 7,582,000 | USD | 0001558370-23-018091 |
| Q3 2023Quarterly · 2023-09-30 | Geography | North America | 19,812,000 | USD | 0001558370-23-018091 |
| Q2 2023Quarterly · 2023-06-30 | Geography | Asia Pacific | 3,938,000 | USD | 0001558370-23-013792 |
| Q2 2023Quarterly · 2023-06-30 | Geography | EMEA | 7,201,000 | USD | 0001558370-23-013792 |
| Q2 2023Quarterly · 2023-06-30 | Geography | North America | 19,890,000 | USD | 0001558370-23-013792 |
| FY 2022Yearly · 2022-12-31 | Product | Consumable And Other Products | 44,804,000 | USD | 0001503274-25-000031 |
| FY 2022Yearly · 2022-12-31 | Product | Grant | 600,000 | USD | 0001503274-25-000031 |
| FY 2022Yearly · 2022-12-31 | Product | License And Service | 649,000 | USD | 0001503274-25-000031 |
| FY 2022Yearly · 2022-12-31 | Product | Other Services | 2,002,000 | USD | 0001503274-25-000031 |
| FY 2022Yearly · 2022-12-31 | Product | Research Services | 23,653,000 | USD | 0001503274-25-000031 |
| FY 2022Yearly · 2022-12-31 | Product | Service And Other Revenue — Instrument Products | 25,004,000 | USD | 0001503274-25-000031 |
| FY 2022Yearly · 2022-12-31 | Product | Service Type Warranties | 8,840,000 | USD | 0001503274-25-000031 |
| Q3 2022Quarterly · 2022-09-30 | Geography | Asia Pacific | 2,717,000 | USD | 0001558370-23-018091 |
| Q3 2022Quarterly · 2022-09-30 | Geography | EMEA | 7,270,000 | USD | 0001558370-23-018091 |
| Q3 2022Quarterly · 2022-09-30 | Geography | North America | 16,659,000 | USD | 0001558370-23-018091 |
| Q2 2022Quarterly · 2022-06-30 | Geography | Asia Pacific | 2,037,000 | USD | 0001558370-23-013792 |
| Q2 2022Quarterly · 2022-06-30 | Geography | EMEA | 7,005,000 | USD | 0001558370-23-013792 |
| Q2 2022Quarterly · 2022-06-30 | Geography | North America | 14,458,000 | USD | 0001558370-23-013792 |
| FY 2021Yearly · 2021-12-31 | Product | Consumable And Other Products | 55,089,000 | USD | 0001558370-24-002205 |
| FY 2021Yearly · 2021-12-31 | Product | Grant | 5,200,000 | USD | 0001558370-24-002205 |
| FY 2021Yearly · 2021-12-31 | Product | Instrument Products | 25,973,000 | USD | 0001558370-24-002205 |
| FY 2021Yearly · 2021-12-31 | Product | License And Service | 648,000 | USD | 0001558370-24-002205 |
| FY 2021Yearly · 2021-12-31 | Product | Other Services | 2,176,000 | USD | 0001558370-24-002205 |
| FY 2021Yearly · 2021-12-31 | Product | Research Services | 14,825,000 | USD | 0001558370-24-002205 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.